These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2841516)

  • 1. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
    Oribe H; Kato R; Noguchi S; Kai T
    Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
    Kushlinskiĭ NE; Liubimova NV; Lemeshko AO; Vasil'ev AV; Davydov MI
    Biull Eksp Biol Med; 1997 Jan; 123(1):98-100. PubMed ID: 9213472
    [No Abstract]   [Full Text] [Related]  

  • 3. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
    Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
    Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
    Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Creatine kinase BB and neuron specific r-enolase as biomarkers for lung cancer].
    Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matsumoto S; Kato K
    Gan No Rinsho; 1987 Nov; 33(14):1763-70. PubMed ID: 2826840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
    Leonardo E; Dogliotti C; Oliaro A
    Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
    Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
    Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
    Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neuron specific enolase (NSE)].
    Odagiri E
    Nihon Rinsho; 1999 Dec; 57 Suppl():540-2. PubMed ID: 10778185
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuron specific enolase].
    Odagiri E
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():717-9. PubMed ID: 16149621
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
    Fujii M; Kiura K; Kamei H; Segawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
    Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
    Hoster M; Kirchheiner T; Rühle KH
    Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum neuron-specific enolase as a marker of lung cancers].
    Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.